Grace Halsey

RELAX: The right gift is out there--as proof, Patient Care has collected 10 more ideas for medical merry-making that range from serious to silly. Enjoy!

In an effort to promote some good-natured holiday healthcare gift-giving, editors at Patient Care® did some window shopping for you.

Seasonal influenza activity is at or above baseline as of week 46, according to the CDC. Get a snapshot of the data.

AHA 2019 ICYMI: Summaries of 11 late-breaking clinical trials presented at the 2019 Scientific Sessions held in Philadelphia, PA, Nov 16-18.

The cost associated with smoking cigarettes doesn't end with the price of a pack. A new study looks deeper in all 50 states plus DC.

After bariatric surgery, risk of a cerebrovascular event among obese patients was found to be signficantly lower than among matched controls. An AHA 2019 preview.

Intensive control of blood pressure may extend survival by 4% to 9%, according to analysis of SPRINT data that will be presented at the AHA 2019 Scientific Sessions next week.

A novel report on US opioid misuse melds results from a Harris Poll of 500 primary care physicians with Quest Diagnostics data on 4.4 million drug monitoring tests.

We preview findings of 2 studies on negative CV effects of e-cigarettes--on metabolic profiles and coronary blood flow--to be presented at the AHA 2019 Scientific Sessions next week.

The American College of Physicians today issued a guidance statement for routine colorectal cancer screening for average-risk adults.

The worst state for drug sales on school grounds? The best state for detox and rehab facilities? Test your best guess with these and 6 more best/worst comparisons.

Screening for depression among ACS patients is widely recommended by professional guidelines, but a new study suggests little return on the investment.

The SGLT2 inhibitor, on October 21, 2019 was granted a label expansion from FDA for the prevention of hospitalization for heart failure in patients with T2D. 

Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.

Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.

For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.

CVS, Walgreens, and Rite Aid have all taken branded and generic ranitidine products off shelves as FDA continues to investigate contamination with a suspected carcinogen.

The CDC made important changes to its flu vaccination recommendations for 2019-2020. Here is a quick review. 

The SGLT-2 inhibitor canagliflozin was FDA-approved on September 30, 2019, to slow progression of diabetic kidney disease and reduce risk of heart failure hospitalization.

Physician salaries vary widely across US cities, among specialties, and between men and women. Find out if you're in touch with the compensation pulse.

Lower bleeding rates but no increase in risk of death, MI, or stroke topped results reported from the TWIGHLIGHT study which compared ticagrelor monotherapy at 3 months post-PCI vs ticarelor plus aspirin.

Oral semaglutide, the first oral GLP-1 receptor agonsist, was approved by the FDA on Sept 20, 2019, becoming the only noninjectable formulation in the class.

Contamination of some lots of ranitidine (Zantac) led the Novartis Sandoz unit today to stop distribution of the drug while the issue is being investigated.

US adults with type 2 diabetes have acheived negligible change in blood glucose levels, blood pressure, LDL-C levels, and smoking status in the past 15 years, according to a new study.

Less than half of PCPs responding to a recent survey chose correct values for prediabetes screening tests and seemed unaware of other evidence-based recommendations for prediabetes.

US adults with diagnosed diabetes are no closer to treatment goals than they were in 2005, according to a new study.

Heavy smokers who quit remain at significantly increased CVD risk for up to 10 years or more, according to new research. Results suggest that current risk estimators may need revision.

Deaths related to synthetic opioids increased from approximately 3000 in 2013 to more than 30 000 in 2018. A new book warns there is more to come.

About 25% of patients with diabetes report asking a physician for a cheaper drug. Skipping doses and pill splitting are tactics used to cut costs.

Recent vaping behavior is the only commonality found among teens and young adults hospitalized in 2 midwestern states, for severe respiratory symptoms.